The global, national, and regional burden and trends in tuberculosis.
Psyence Biomed Enters into Agreement to Acquire Stake in PsyLabs | Psychedelic Invest
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that it has entered into a conditional share sale